Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank92
Year-over-Year Change
Year-over-year net income growth rate
Latest
19.54%
↑ 376% vs avg
Percentile
P92
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-7.08%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 19.54% |
| Q2 2025 | 12.99% |
| Q1 2025 | 22.15% |
| Q4 2024 | 7.53% |
| Q3 2024 | 75.33% |
| Q2 2024 | -114.37% |
| Q1 2024 | -48.14% |
| Q4 2023 | 3.16% |
| Q3 2023 | -0.21% |
| Q2 2023 | 3.92% |
| Q1 2023 | -14.19% |
| Q4 2022 | 3.60% |
| Q3 2022 | -2.78% |
| Q2 2022 | -20.61% |
| Q1 2022 | 12.53% |
| Q4 2021 | -23.18% |
| Q3 2021 | -0.14% |
| Q2 2021 | -41.49% |
| Q1 2021 | -11.12% |
| Q4 2020 | -10.85% |
| Q3 2020 | -39.52% |
| Q2 2020 | -7.28% |
| Q1 2020 | 2.78% |
| Q4 2019 | -4.56% |
| Q3 2019 | 0.90% |
| Q2 2019 | -17.05% |
| Q1 2019 | 0.00% |